Speakers

in alphabetical ordner

 

Mitchell Albert
Lakehead University—Thunder Bay Regional Health Research Institute, Canada
on 129Xe MRI for pulmonary gas exchange and capillary flow in COVID-19

David Baldwin
University of Nottingham | School of Medicine, Nottingham, UK
on How to build an effective screening program

R. Graham Barr
Columbia University, New York, United States
on Cardiopulmonary imaging in COPD

Delphine L. Chen
University of Washington, Seattle, United States
on The emerging role for PET imaging in Lung disease

Bastiaan Driehuys
Duke University School of Medicine, Durham, United States
on Hyperpolarized 129Xe MRI for novel insights into Pulmonary Vascular Disease

Rachel Eddy
University of British Columbia, Vancouver, Canada
on Role of MR Functional Imaging

Jin Mo Goo
Seoul National University Hospital (SNUH) Radiology, South Korea
on Novel CT biomarker for monitoring ILD

Hiroto Hatabu
Brinham and Women´s Hospital (BWH) and Harvard Medical School (HMS), Boston, United States
on Functional Lung MRI - emerging role in COPD

Marius M Hoeper
Hannover Medical School, Germany
on Pulmonary Hypertension - the clinical perspective

Eric A. Hoffman
Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, United States
on Novel Structure-Function CT markers in COPD

Christopher Johns 
The University of Sheffield and Hull York Medical School, UK
on The emerging role of functional lung MRI in ILD

Till Kaireit
Hannover Medical School (MHH), Germany
on The importance of workflow in LC screening – The HANSE study

Hans-Ulrich Kauczor
Heidelberg University Hospital, Germany
on COVID-19 - the role of imaging and future perspectives

Agilo Luitger Kern
Hannover Medical School (MHH), Germany
on Microstructure Imaging of the lung with hyperpolarized Gas MRI

Mark Kuehnel
Hannover Medical School (MHH), Germany
on COVID-19 – Novel insights from Microstructure Imaging

David A. Lynch
National Jewish Health, Denver, United States
on ILDs - What the radiologist needs to know

Mizuki Nishino
Harvard Medical School, Boston, MA, United States
on Therapy response Imaging – Current Status and novel developments

Yoshiharu Ohno
Fujita Health University School of Medicine, Toyoake, Japan
on Role of CT Functional Imaging

Matthijs Oudkerk
University of Groningen, The Netherlands
on LC screening: Nodule management – Present and Future

Franz Pfeiffer
TUM - Technical University Munich, Germany
on New Horizons: Dark field imaging of the lungs

Antje Prasse
Hannover Medical School (MHH) and Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, German
on Critical Clinical Issues in IPF

Giles Santyr
The Hospital for Sick Children Research Institute and University of Toronto, Canada
on Opportunities of hyperpolarized 129Xe gas MRI in children with lung disease

Mark L. Schiebler
University of Wisconsin-Madison School of Medicine and Public Health, United States
on Pulmonary embolism: Acute, Chronic and AI

Joon Beom Seo
Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
on Deep learning: a quantum leap for Lung Imaging

Andrew Swift
The University of Sheffield, UK
on The role of imaging in pulmonary hypertension

Edwin J.R. van Beek
The University of Edingurgh, UK
on Past, Present and Future of Functional Lung Imaging

Jens Vogel-Claussen
Hannover Medical School (MHH), Germany
on LC Screening: What about the heart and other lung disease?

Claus Franz Vogelmeier
UKGM - University Hospital  Marburg, Germany
on Critical Clinical Issues in COPD

Erika von Mutius
Dr. von Hauner Children's Hospital and Ludwig Maximilian University of Munich, Germany
on Critical Clinical Issues in Asthma

Andreas Vorkrebenzev
Hannover Medical School (MHH), Germany
on Functional Lung Imaging with Proton MRI - state of the art

Willi Wagner
Heidelberg University Hospital, Germany
on Multiscale imaging of the human lung

Tobias Welte
Hannover Medical School (MHH), Germany
on Lessons learned from the COVID-19 pandemic

Mark Oliver Wielpütz
Heidelberg University Hospital, Germany
on The growing clinical role of functional lung MRI in CF

Jim Wild
The University of Sheffield, UK
on 19F and 129 Xe Lung  MRI – ready for clinical translation

Jason C. Woods
Cincinnati Children's Hospital Medical Center, United States
on The emerging clinical role of functional lung MRI in newborns and infants